185 related articles for article (PubMed ID: 23131665)
1. The role of epigenetic transcriptional regulation in BRCA1-mediated tumor suppression.
Chang S; Sharan SK
Transcription; 2013; 4(1):24-8. PubMed ID: 23131665
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic control of an oncogenic microRNA, miR-155, by BRCA1.
Chang S; Sharan SK
Oncotarget; 2012 Jan; 3(1):5-6. PubMed ID: 22403740
[No Abstract] [Full Text] [Related]
3. UHRF1 is associated with epigenetic silencing of BRCA1 in sporadic breast cancer.
Jin W; Chen L; Chen Y; Xu SG; Di GH; Yin WJ; Wu J; Shao ZM
Breast Cancer Res Treat; 2010 Sep; 123(2):359-73. PubMed ID: 19943104
[TBL] [Abstract][Full Text] [Related]
4. Crucial role for early growth response-1 in the transcriptional regulation of miR-20b in breast cancer.
Li D; Ilnytskyy Y; Kovalchuk A; Khachigian LM; Bronson RT; Wang B; Kovalchuk O
Oncotarget; 2013 Sep; 4(9):1373-87. PubMed ID: 23945289
[TBL] [Abstract][Full Text] [Related]
5. BRCA1 and microRNAs: emerging networks and potential therapeutic targets.
Chang S; Sharan SK
Mol Cells; 2012 Nov; 34(5):425-32. PubMed ID: 22936386
[TBL] [Abstract][Full Text] [Related]
6. BRCA1 as a tumor suppressor linked to the regulation of epigenetic states: keeping oncomiRs under control.
Stefansson OA; Esteller M
Breast Cancer Res; 2012 Mar; 14(2):304. PubMed ID: 22423979
[TBL] [Abstract][Full Text] [Related]
7. Enforced expression of hsa-miR-125a-3p in breast cancer cells potentiates docetaxel sensitivity via modulation of BRCA1 signaling.
Xu X; Lv YG; Yan CY; Yi J; Ling R
Biochem Biophys Res Commun; 2016 Oct; 479(4):893-900. PubMed ID: 27693788
[TBL] [Abstract][Full Text] [Related]
8. Tumor suppressor BRCA1 epigenetically controls oncogenic microRNA-155.
Chang S; Wang RH; Akagi K; Kim KA; Martin BK; Cavallone L; ; Haines DC; Basik M; Mai P; Poggi E; Isaacs C; Looi LM; Mun KS; Greene MH; Byers SW; Teo SH; Deng CX; Sharan SK
Nat Med; 2011 Sep; 17(10):1275-82. PubMed ID: 21946536
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-155, induced by FOXP3 through transcriptional repression of BRCA1, is associated with tumor initiation in human breast cancer.
Gao S; Wang Y; Wang M; Li Z; Zhao Z; Wang RX; Wu R; Yuan Z; Cui R; Jiao K; Wang L; Ouyang L; Liu R
Oncotarget; 2017 Jun; 8(25):41451-41464. PubMed ID: 28562349
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic changes in BRCA1-mutated familial breast cancer.
Downs B; Wang SM
Cancer Genet; 2015 May; 208(5):237-40. PubMed ID: 25800897
[TBL] [Abstract][Full Text] [Related]
11. [Advance in researches on BRCA1].
Yan JH; Ye QN; Huang CF
Yi Chuan; 2004 May; 26(3):367-72. PubMed ID: 15640022
[TBL] [Abstract][Full Text] [Related]
12. Dysregulation of the BRCA1/long non-coding RNA NEAT1 signaling axis contributes to breast tumorigenesis.
Lo PK; Zhang Y; Wolfson B; Gernapudi R; Yao Y; Duru N; Zhou Q
Oncotarget; 2016 Oct; 7(40):65067-65089. PubMed ID: 27556296
[TBL] [Abstract][Full Text] [Related]
13. Effects on human transcriptome of mutated BRCA1 BRCT domain: a microarray study.
Iofrida C; Melissari E; Mariotti V; Guglielmi C; Guidugli L; Caligo MA; Pellegrini S
BMC Cancer; 2012 May; 12():207. PubMed ID: 22646717
[TBL] [Abstract][Full Text] [Related]
14. BRCA1 suppresses osteopontin-mediated breast cancer.
El-Tanani MK; Campbell FC; Crowe P; Erwin P; Harkin DP; Pharoah P; Ponder B; Rudland PS
J Biol Chem; 2006 Sep; 281(36):26587-601. PubMed ID: 16807234
[TBL] [Abstract][Full Text] [Related]
15. Structural basis for cell cycle checkpoint control by the BRCA1-CtIP complex.
Varma AK; Brown RS; Birrane G; Ladias JA
Biochemistry; 2005 Aug; 44(33):10941-6. PubMed ID: 16101277
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic tumor suppression by BRCA1.
Velkova A; Monteiro AN
Nat Med; 2011 Oct; 17(10):1183-5. PubMed ID: 21988990
[No Abstract] [Full Text] [Related]
17. BRCA1 regulation of transcription.
Rosen EM; Fan S; Ma Y
Cancer Lett; 2006 May; 236(2):175-85. PubMed ID: 15975711
[TBL] [Abstract][Full Text] [Related]
18. DNA methylation and miRNAs regulation in hereditary breast cancer: epigenetic changes, players in transcriptional and post- transcriptional regulation in hereditary breast cancer.
Pinto R; De Summa S; Pilato B; Tommasi S
Curr Mol Med; 2014 Jan; 14(1):45-57. PubMed ID: 24295492
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA in breast cancer: The association with BRCA1/2.
Petrovic N; Davidovic R; Bajic V; Obradovic M; Isenovic RE
Cancer Biomark; 2017; 19(2):119-128. PubMed ID: 28128741
[TBL] [Abstract][Full Text] [Related]
20. Dynamic interactions between the promoter and terminator regions of the mammalian BRCA1 gene.
Tan-Wong SM; French JD; Proudfoot NJ; Brown MA
Proc Natl Acad Sci U S A; 2008 Apr; 105(13):5160-5. PubMed ID: 18375767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
